US Defense Secretary Pete Hegseth has proposed annual testosterone screenings for troops aged 30 and older, with voluntary hormone therapy for those deemed deficient.

The plan aims to restore a 'warrior ethos' by optimizing natural capabilities, but experts like Adrian Dobs from Johns Hopkins University argue it oversimplifies complex endocrinology.

Dobs highlights issues such as circadian rhythm variations in testosterone levels, the impact of stress on hormone production, and the risks of testosterone replacement therapy, including testicular atrophy, reduced sperm count, and cardiovascular risks.The proposal has drawn criticism for lacking scientific justification and ignoring underlying health conditions.

Hegseth's policies also include purging transgender service members and imposing 'male standard' fitness tests, raising concerns about discriminatory practices.The article underscores the lack of concrete evidence supporting the plan's benefits and questions its alignment with military needs.